Talus Replacement Registry
Key facts
- Who runs it
- Kyle Schweser MD
- Where
- Columbia, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 1 Jan 2020
- Expected to end
- 1 May 2027
- Type of study
- Observational
- Treatments tested
- 3D talar augmentation
- Record updated
- 28 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Subjects age 18 years or above at time of screening
- Condition satisfies requirement for total talus replacement
- Able to consent and participate in the study
- No previous history of septic arthritis involving the hindfoot/midfoot
- Previous ability to ambulate
Who cannot take part
- Active infection, sepsis, osteomyelitis or history of septic arthritis involving the hindfoot/midfoot
- Condition does not qualify for a total talus replacement
- Unable to consent or participate in the study secondary to mental status
- Patients who are pregnant or imprisoned
- Planned relocation or unable to return for required follow-up visits
Where in United States
- University of MissouriColumbia, United StatesContact: Ennio R EspositoTaking people
About the trial
What the trial wants to find out
Avascular necrosis of the talus is a difficult problem to manage, especially in the young and healthy. The only option, historically, has been a talectomy and hindfoot fusion. While this is a viable option, it is not without its morbidity. Arthritis of surrounding joints is common, occurring anywhere from 1-10 years after the procedure. This is especially true in younger patients, where loss of motion can be life altering both physically and mentally. The search for alternatives has been limited. Recently, 3D printing has become more ubiquitous and affordable and newer medical alternatives have arisen thanks to this technology. The 3D custom talus is relatively new in the orthopaedic community, but has been used at several centers with good success. It has been shown to re-establish the normal alignment of the foot, preserve motion (with some achieving almost physiologic motion), and allow for almost normal ambulation. However, the data is still limited and further study is necessary. Our facility was recently approved to perform this procedure. Our hypothesis is that custom 3D printed talar body replacements, either used alone or with total ankle replacements, will maintain physiologic motion, have no difference in complications when compared to hindfoot fusions with allograft, lead to good outcome scores and patient satisfaction scores. Patients diagnosed with avascular necrosis of the talus who have already decided to undergo a procedure involving a 3D custom talus as part of their standard care (talar replacement, total ankle/total talus, etc) will be enrolled in the study. Patients will follow standard post-operative protocols and return to clinic at designated time periods (2 weeks, 6 weeks, 3 months, 6 months, 1 year). X-ray evaluation, Range of motion, return to ambulation, walking speed and patient reported outcomes will be evaluated at each visit. Data will then be compared with baseline measurements and use to determine the progression of patients over time after the procedure
The group in the trial
- 3D talar group
Patients that will undergo a 3D custom talar augment
Treatment: 3D talar augmentation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 28 April 2026